Article Details

J&J and Pfizer Settle Remicade Biosimilar Antitrust Suit

Retrieved on: 2021-08-04 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

J&J and Pfizer Settle Remicade Biosimilar Antitrust Suit. View article details on hiswai:

Excerpt

In its September 20, 2017 complaint, Pfizer alleged that J&J violated the Sherman Act and Clayton Act by entering into de facto exclusivity agreements ...

Article found on: www.jdsupra.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up